SEC
TMO icon

Seven Eight Capital’s Thermo Fisher Scientific TMO Stock Holding History

Seven Eight Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,574
Closed -$3.45M – 594
2024
Q3 		$3.45M Buy
5,574
+2,988
+116% +$1.77M 0.31% 71
2024
Q2 		$1.43M Buy
2,586
+588
+29% +$337K 0.15% 237
2024
Q1 		$1.16M Buy
+1,998
New +$1.12M 0.12% 265
2023
Q4 		– Sell
-5,519
Closed -$2.79M – 833
2023
Q3 		$2.79M Sell
5,519
-2,794
-34% -$1.49M 0.33% 70
2023
Q2 		$4.34M Buy
8,313
+5,646
+212% +$3.05M 0.72% 24
2023
Q1 		$1.54M Buy
2,667
+1,967
+281% +$1.11M 0.32% 86
2022
Q4 		$385K Buy
+700
New +$371K 0.1% 268
2022
Q1 		– Sell
-868
Closed -$579K – 690
2021
Q4 		$579K Buy
+868
New +$542K 0.1% 247
2019
Q1 		– Sell
-14,900
Closed -$3.33M – 727
2018
Q4 		$3.33M Sell
14,900
-49,700
-77% -$11.7M 0.19% 156
2018
Q3 		$15.8M Buy
64,600
+45,700
+242% +$10.5M 0.96% 10
2018
Q2 		$3.92M Buy
+18,900
New +$4.01M 0.27% 119
2017
Q4 		– Sell
-1,400
Closed -$265K – 580
2017
Q3 		$265K Buy
+1,400
New +$254K 0.03% 395
2017
Q2 		– Sell
-2,900
Closed -$445K – 677
2017
Q1 		$445K Sell
2,900
-2,400
-45% -$367K 0.09% 277
2016
Q4 		$748K Buy
+5,300
New +$781K 0.15% 228
2015
Q4 		– Sell
-3,400
Closed -$416K – 681
2015
Q3 		$416K Buy
+3,400
New +$443K 0.36% 89
2015
Q2 		– Sell
-100
Closed -$13K – 658
2015
Q1 		$13K Sell
100
-1,300
-93% -$168K 0.02% 380
2014
Q4 		$175K Buy
+1,400
New +$170K 0.29% 131
2014
Q3 		– Sell
-600
Closed -$71K – 672
2014
Q2 		$71K Buy
+600
New +$70.6K 0.07% 338
2014
Q1 		– Sell
-1,300
Closed -$145K – 491
2013
Q4 		$145K Buy
+1,300
New +$129K 0.16% 203

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Seven Eight Capital's TMO Position: Q4 2024 in Review

Seven Eight Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 5,574 shares — an estimated $3.45M sold.

Seven Eight Capital first reported a position in TMO in Q4 2013 and held it in 19 quarters. The position peaked at $15.8M in Q3 2018. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Seven Eight Capital reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 5,574 Thermo Fisher Scientific shares in Q4 2024, an estimated $3.45M.
  • Seven Eight Capital first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 19 quarters.
  • Seven Eight Capital's Thermo Fisher Scientific position peaked at $15.8M in Q3 2018.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.